• March 2022: Lu-177 vipivotide tetraxetan & Ga-68 gozetotide receive FDA approval for prostate cancer
  • May 2020: Cerianna (F-18 fluoroestradiol) receives FDA approval for ER+ breast cancer imaging
  • Access the latest issues of the JNM and the JNMT
  • Learn about the Facilitating Innovative Nuclear Diagnostics (FIND) Act
  • March 2021:SNMMI Statement on COVID-19 and Ventilation/Perfusion (V/Q) Lung Studies
  • March 2021:SNMMI Statement: The Effect of COVID-19 Vaccination on FDG PET/CT
Contact Us

Please use this form to contact the MVC. Your comments will be sent to the Executive Director and then forwarded to the appropriate Board member if needed. You should expect a response soon.

Name*:
Phone number:
Email address*:
Comments and questions*:

Enter web form code*: Contact Us form
Reload Image

* - required fields.